comparemela.com

Latest Breaking News On - Castleman disease collaborative network - Page 8 : comparemela.com

EUSA Pharma: SYLVANT (siltuximab) Recommended by the National Comprehensive Cancer Network (NCCN) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless of histopathologic subtype

(1) EUSA Pharma (UK) Limited ( EUSA Pharma ), a global biopharmaceutical company focused on oncology and rare diseases, announced that the National Comprehensive Cancer Network (NCCN ) for B-Cell Lymphomas to include siltuximab (SYLVANT ) as the preferred primary treatment for patients with human immunodeficiency virus-negative [HIV(-)] and human herpesvirus 8-negative [HHV-8(-)] multicentric Castleman disease (MCD), also known as idiopathic multicentric Castleman disease (iMCD), regardless of histopathologic subtype. 1 Siltuximab is currently approved in more than 40 countries worldwide for the treatment of all histopathologic subtypes of iMCD, a rare, life-threatening and debilitating orphan condition of the lymph nodes and related tissues. 2,3 The update is based on a 2020 publication which demonstrated that there is insufficient evidence to guide treatment based solely on lymph node histopathologic subtype.

Rare Disease Day – why it s important to show your stripes

Rare Disease Day – why it’s important to show your stripes Nucleus Global s EU Strategy Director, Amanda Henkel, writes about the importance of continuing to raise awareness of rare diseases Rare Disease Day (https://www.rarediseaseday.org/) on 28 February is intended to raise awareness among policymakers and the public about rare diseases and their impact on the lives of patients and their families. If you’re active on social media, you can’t have failed to notice the splashes of pink, blue and green accompanying posts of the annual event. In the US, the zebra is the official symbol of rare diseases (due to the uniqueness of the black and white stripes) and the National Organization for Rare Disorders (NORD) are using the hashtag ‘Show Your Stripes’ to promote Rare Disease Day – but what does it mean, and why should we get involved?

Ocugen Establishes Vaccine Scientific Advisory Board

Ocugen Establishes Vaccine Scientific Advisory Board
mychesco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mychesco.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.